Around Directive 2001/20/EC
Citations, amendments, and UK copies of EU law. Bigger circles are relied on more.
Citations, amendments, and UK copies of EU law. Bigger circles are relied on more.
44 laws and 45 links: citations, amendments, and UK copies of EU law. Bigger circles are relied on more.
| Law | Links on map | Importance |
|---|---|---|
| EUDirective 95/46/EC | 1 | 8.81 |
| EUDirective (EU) 2019/1937 | 1 | 0.78 |
| EUDirective 2011/24/EU | 1 | 0.50 |
| EUDirective 2001/83/EC | 2 | 0.25 |
| EURegulation (EC) No 726/2004 | 1 | 0.15 |
| EUDirective 2001/20/EC | 45 | 0.00 |
| EURegulation (EC) No 1901/2006 |
| 2 |
| 0.00 |
| EUCommission Directive 2005/28/EC | 1 | 0.00 |
| EUCOVID-19 | 1 | 0.00 |
| EURegulation (EC) No 596/2009 | 1 | 0.00 |
| EUCouncil Decision (EU) 2026/1535 | 1 | 0.00 |
| EURegulation (EU) No 536/2014 | 1 | 0.00 |
| EUDirective (EU) 2022/642 | 1 | 0.00 |
| EUDirective 2010/84/EU | 1 | 0.00 |
| EUCommission Implementing Regulation (EU) 2017/556 | 1 | 0.00 |
| EUCouncil Decision 2013/455/EU | 1 | 0.00 |
| EUC-681/16 Pfizer Ireland Pharmaceuticals, Operations Support Group | 1 | 0.00 |
| EURegulation (EU) 2023/1322 | 1 | 0.00 |
| EUCommission Implementing Regulation (EU) 2022/20 | 1 | 0.00 |
| EUCommission Delegated Regulation (EU) 2017/1569 | 1 | 0.00 |
| EUC-118/24 Laboratoires Eurogenerics and Theramex France | 1 | 0.00 |
| EUM2Beauté Cosmetics GmbH v Bundesrepublik Deutschland (C-616/20) | 1 | 0.00 |
| EUSanten SAS v Directeur général de l’Institut national de la propriété industrielle (C-673/18) | 1 | 0.00 |
| EUPTC Therapeutics International Ltd v European Medicines Agency (T-718/15) | 1 | 0.00 |
| EUMedac Gesellschaft für klinische Spezialpräparate mbH v European Commission (T-549/19) | 1 | 0.00 |
| EUT-223/20 Orion v Commission | 1 | 0.00 |
| EUCommission Implementing Regulation (EU) No 520/2012 | 1 | 0.00 |
| EUkohlpharma GmbH v Bundesrepublik Deutschland (C-602/19) | 1 | 0.00 |
| EUC-178/20 Pharma Expressz | 1 | 0.00 |
| EUNovartis Pharma GmbH v Apozyt GmbH (C-535/11) | 1 | 0.00 |
| EUC-567/16 Merck Sharp & Dohme Corporation | 1 | 0.00 |
| EUCommission Regulation (EU) No 488/2012 | 1 | 0.00 |
| EULaboratoires CTRS v European Commission (T-301/12) | 1 | 0.00 |
| EURegulation (EC) No 1394/2007 | 1 | 0.00 |
| EUCommission Delegated Regulation (EU) 2022/2239 | 1 | 0.00 |
| EUCommission Decision (EU) 2021/1240 | 1 | 0.00 |
| EUCommission Delegated Decision 2014/286/EU | 1 | 0.00 |
| EUCommission Decision 2008/646/EC | 1 | 0.00 |
| EUSecond Council Directive 75/319/EEC of 20 May 1975 on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products | 1 | 0.00 |
| EU1999/468/EC: Council Decision of 28 June 1999 laying down the procedures for the exercise of implementing powers conferred on the Commission | 1 | 0.00 |
| EUCouncil Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products | 1 | 0.00 |
| EUCouncil Regulation (EEC) No 2309/93 of 22 July 1993 laying down Community procedures for the authorization and supervision of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products | 1 | 0.00 |
| EUCommission Directive 91/356/EEC of 13 June 1991 laying down the principles and guidelines of good manufacturing practice for medicinal products for human use | 1 | 0.00 |
| EUNycomed Danmark ApS v European Medicines Agency (EMA) (T-52/09) | 1 | 0.00 |